Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-02-06

Clinical Trial Update: Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis [Phase 4]

View source ↗

Summary

Phase 4 trial update on simvastatin gel with perforated resorbable membranes for intrabony defects in chronic periodontitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Simvastatin Gel with Perforated Resorbable Membranes (simvastatin)

Snippet

Sponsor: Ain Shams University | Conditions: Chronic Periodontitis | Phase 4 | Status: COMPLETED